Guangdong Lifestrong Pharmacy Co., Ltd. (SHE:301111)

China · Delayed Price · Currency is CNY

19.90

+0.26 (1.32%)

Apr 30, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Medicine		271.29M	289.57M	272.15M	336.07M	-
Medicine Growth		-6.31%	6.40%	-19.02%	-	-
Pieces		1.48M	-	-	-	-
Medical Services and Health Management		1.60M	-	-	-	-
Others		4.27M	2.82M	-	346.98K	-
Others Growth		51.23%	-	-	-	-
Medical Instruments		-	-	11.14M	13.37M	-
Medical Instruments Growth		-	-	-16.69%	-	-
Unallocated Others		-	-	46.70K	-	-
Total		278.64M	292.40M	283.34M	349.79M	-
Total Growth		-4.71%	3.20%	-19.00%	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China		278.64M	292.40M	283.34M	349.79M	340.96M
China Growth		-4.71%	3.20%	-19.00%	2.59%	7.70%
Total		278.64M	292.40M	283.34M	349.79M	340.96M
Total Growth		-4.71%	3.20%	-19.00%	2.59%	7.70%

Source: S&P Global Market Intelligence.